Aza-and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
申请人:——
公开号:US20040034221A1
公开(公告)日:2004-02-19
Aza- and polyaza-naphthalenyl carboxamide derivatives including certain quinoline carboxamide and naphthyridine carboxamide derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
AZA- AND POLYAZA-NAPHTHALENYL-CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS
申请人:Merck & Co., Inc.
公开号:EP1326611A1
公开(公告)日:2003-07-16
EP1326611A4
申请人:——
公开号:EP1326611A4
公开(公告)日:2004-04-07
US6919351B2
申请人:——
公开号:US6919351B2
公开(公告)日:2005-07-19
[EN] AZA- AND POLYAZA-NAPHTHALENYL-CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS<br/>[FR] AZANAPHTHALENYLCARBOXAMIDES ET POLYAZANAPHTHALENYLCARBOXAMIDES UTILES EN TANT QU'INHIBITEURS DE LA VIH INTEGRASE
申请人:MERCK & CO INC
公开号:WO2002030426A1
公开(公告)日:2002-04-18
Aza- and polyaza-naphthalenyl carboxamide derivatives including certain quinoline carboxamide and naphthyridine carboxamide derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, as compounds or pharmaceutically acceptable salts, or as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.